World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
52963
World Ranking
6408
National Ranking
3414

Research.com Recognitions

  • 1952 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Paul D. Miller is a researcher affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their main field of study is Medicine, with a focus on several subfields including Oncology, Nephrology, Orthopedics and Sports Medicine, Emergency Medicine, and Rheumatology.

The scientist's research primarily covers topics related to bone health and treatments, parathyroid disorders and treatments, and bone health and osteoporosis research. Additional topics include heterotopic ossification and related conditions, medical imaging and pathology studies, endometriosis research and treatment, and the effects of estrogen and related hormones.

Their recent publications include:

  • "Burosumab for the Treatment of Tumor-Induced Osteomalacia," 2020, Journal of Bone and Mineral Research
  • "Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics," 2021, American Journal of Kidney Diseases
  • "Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease," 2020, The Journal of Clinical Endocrinology & Metabolism
  • "History of etidronate," 2020, Bone
  • "Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density," 2021, Clinical Drug Investigation

Frequent coauthors in their publications include Michael Pazianas, Suzanne M. Jan de Beur, Munro Peacock, Karl Insogna, and Tricia Cimms.

The venues where Paul D. Miller's work is often published include:

  • Journal of Bone and Mineral Research
  • Journal of the Endocrine Society
  • Equity in Education & Society
  • Obstetrics and Gynecology
  • American Journal of Kidney Diseases

Paul D. Miller was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 1952.

Best Publications

  • Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis: A Randomized Controlled Trial

    Steven T. Harris;Nelson B. Watts;Harry K. Genant;Clark D. McKeever

  • Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

    Michael R. McClung;Piet Geusens;Paul D. Miller;Hartmut Zippel

  • Denosumab in postmenopausal women with low bone mineral density

    Michael R. McClung;E. Michael Lewiecki;Stanley B. Cohen;Michael A. Bolognese

  • Primer on the metabolic bone diseases and disorders of mineral metabolism

    John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston

  • Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the national osteoporosis risk assessment

    Ethel S. Siris;Paul D. Miller;Elizabeth Barrett-Connor;Kenneth G. Faulkner

  • A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

    Charles H Chesnut;Stuart Silverman;Kim Andriano;Harry Genant

  • Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

    N B Watts;S T Harris;H K Genant;R D Wasnich

  • American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2016

    Pauline M. Camacho;Steven M. Petak;Neil Binkley;Dima L. Diab

  • Bone mineral density thresholds for pharmacological intervention to prevent fractures

    Ethel S. Siris;Ya Ting Chen;Thomas A. Abbott;Elizabeth Barrett-Connor

  • Alendronate for the treatment of osteoporosis in men

    Eric Orwoll;Mark Ettinger;Stuart Weiss;Paul Miller

  • Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

    Anthony B. Hodsman;Douglas C. Bauer;David W. Dempster;Larry Dian

  • Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial

    Paul D. Miller;Gary Hattersley;Bente Juel Riis;Gregory C. Williams

  • Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.

    Paul D. Miller;Michael A. Bolognese;E. Michael Lewiecki;Michael R. McClung

  • Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.

    Marc C. Hochberg;Susan Greenspan;Richard D. Wasnich;Paul Miller

  • Osteoporosis and Fracture Risk in Women of Different Ethnic Groups

    Elizabeth Barrett-Connor;Ethel S Siris;Lois E Wehren;Paul D Miller

  • Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.

    Henry G. Bone;Michael A. Bolognese;Chui Kin Yuen;David L. Kendler

  • Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density

    Richard D. Wasnich;Paul D. Miller

  • Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

    Michael McClung;Steven T. Harris;Paul D. Miller;Douglas C. Bauer

  • Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women

    P. D. Ross;H. K. Genant;J. W. Davis;P. D. Miller

  • Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

    Nelson B. Watts;Steven T. Harris;Harry K. Genant;Edward D. Wasnich

Frequent Co-Authors

E. Michael Lewiecki
E. Michael Lewiecki University of New Mexico
Michael R. McClung
Michael R. McClung Australian Catholic University
John P. Bilezikian
John P. Bilezikian Columbia University
Robert R. Recker
Robert R. Recker Creighton University
Jacques P. Brown
Jacques P. Brown Université Laval
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Steven Boonen
Steven Boonen KU Leuven
Jonathan D. Adachi
Jonathan D. Adachi McMaster University
Felicia Cosman
Felicia Cosman Columbia University
Ian R. Reid
Ian R. Reid University of Auckland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up a wide range of related degree options and potential career paths. For those interested in patient care but seeking more flexible admissions, you might explore a nursing school that doesn’t require teas. These programs can remove certain standardized testing barriers and help students begin their nursing journey more quickly.

If you're drawn to the business side of healthcare, an online healthcare management degree can open doors to leadership roles within hospitals, clinics, or other health organizations. For registered nurses aiming to advance their careers, stepping up through adn to fnp bridge programs provides a pathway to become a Family Nurse Practitioner with greater autonomy and specialization.

Additionally, if you're passionate about wellness and preventive care, earning an online degree nutrition can lead to rewarding roles as a nutritionist or health educator. Each of these options represents a dynamic approach to healthcare education, offering flexibility and career opportunities beyond traditional medical school.

Best Scientists Citing Paul D. Miller

Trending Scientists